Recovers natural whitness
of your eyes
of your eyes
Vasoconstrictor eye drops
with moisturizing effect
0,05% naphazoline +
0,1% hyaluronic acid
with moisturizing effect
0,05% naphazoline +
0,1% hyaluronic acid
CONTAINS HYALURONIC ACID
SIGIDA CRYSTAL - THE FIRST VASOCONSTRICTOR EYE DROPS WITH MOISTURIZING EFFECT
SIGIDA CRYSTAL - THE FIRST VASOCONSTRICTOR EYE DROPS WITH REWETTING EFFECT
Quickly relieves eye redness, swelling and irritation
Produces an additional moisturizing effect
Preservative- and dye-free
Easy-to-use compact single dosage form and OSD-bottle
Recommendations for use
SIGIDA Crystal drops have vasoconstrictor and moisturizing effects. That is why the medication quickly and carefully relieves eye redness caused by dilation of blood vessels due to irritation and allergic reactions. The medication also helps to relieve eye redness caused by foreign bodies, makeup or chlorinated water. It quickly relieves irritation and edema, removes eyelid swelling and redness.
Composition
1 ml of the medication contains:
Active ingredient:
0.5 mg naphazoline nitrate (Naphthyzin)
Excipients:
18.7 mg boric acid
1.125 mg macrogol 300
1.0 mg sodium hyaluronate
0.5 mg disodium dihydrogen ethylenediaminetetraacetate (Trilon B)
1 M sodium hydroxide solution, pH 4.0-7.0
or 0.1 M nitric acid solution
Water for injections (up to 1 ml)
Active ingredient:
0.5 mg naphazoline nitrate (Naphthyzin)
Excipients:
18.7 mg boric acid
1.125 mg macrogol 300
1.0 mg sodium hyaluronate
0.5 mg disodium dihydrogen ethylenediaminetetraacetate (Trilon B)
1 M sodium hydroxide solution, pH 4.0-7.0
or 0.1 M nitric acid solution
Water for injections (up to 1 ml)
Use
1. Open the pouch, separate one single dosage form, return the rest to the pouch
2. Open the single dosage form (turn the cap with rotatory motions and remove the valve)
3. Instil the required amount of drops in the eyes. One single dosage form is sufficient to instil drops in both eyes
4. Cautiously close the eye after instilling drops. Do not blink or open the eye for approximately 2 minutes to allow the medication to adsorb.
5. Press the medial angle of the closed eyelid for 1-2 minutes after instilling drops with a crook of the finger to avoid having drops in the nasal cavity
2. Open the single dosage form (turn the cap with rotatory motions and remove the valve)
3. Instil the required amount of drops in the eyes. One single dosage form is sufficient to instil drops in both eyes
4. Cautiously close the eye after instilling drops. Do not blink or open the eye for approximately 2 minutes to allow the medication to adsorb.
5. Press the medial angle of the closed eyelid for 1-2 minutes after instilling drops with a crook of the finger to avoid having drops in the nasal cavity
Contraindications
- Hypersensitivity to medication components ·
- Angle-closure glaucoma ·
- Children under 2
SIGIDA MANUFACTURING SITE
SIGIDA MANUFACTURING SITE
Sigida Crystal is manufactured in Saint Petersburg using state-of-the-art high-technology Solopharm equipment. This allows to ensure a European quality product for a low price.
The Solopharm plant for manufacturing medications in sterile liquid dosage forms was built in 2013 according to international GMP quality standards using the cleanroom technology. The plant is equipped with modern high-technology European equipment and state-of-the-art systems for heating, ventilation and water treatment.
The Solopharm plant for manufacturing medications in sterile liquid dosage forms was built in 2013 according to international GMP quality standards using the cleanroom technology. The plant is equipped with modern high-technology European equipment and state-of-the-art systems for heating, ventilation and water treatment.
Solopharm's state-of-the-art lines
Solopharm has an R&D department and laboratories to ensure full-scale pharmaceutical development and quality control of the incoming raw materials, all production stages and end products.
Sigida Crystal is manufactured in Saint Petersburg using state-of-the-art high-technology Solopharm equipment. This allows offering a European quality product for a low price.
The Solopharm plant for manufacturing medications in sterile liquid dosage forms was built in 2013 according to international GMP quality standards using the cleanroom technology. The plant is equipped with modern high-technology European equipment and state-of-the-art systems for heating, ventilation and water treatment.
The Solopharm plant for manufacturing medications in sterile liquid dosage forms was built in 2013 according to international GMP quality standards using the cleanroom technology. The plant is equipped with modern high-technology European equipment and state-of-the-art systems for heating, ventilation and water treatment.
Solopharm's rocket-science level lines
Solopharm has an R&D department and laboratories to ensure full-scale pharmaceutical development and quality control of the incoming raw materials, all production stages and end products.
Please read the package inserts.
Consult your healthcare professional before use.
Consult your healthcare professional before use.
71/2 Industrialny Prospekt, Saint Petersburg, 195279 Russia
Sales department: sales4@grotexmed.com +7 (812) 385-47-87, ext. 404
For cooperation offers: grtx@grotexmed.com
Our medications: Taurine-SOLOpharm| Oxyfrin | Gylan | LinAqua | Trekrezan
Sales department: sales4@grotexmed.com +7 (812) 385-47-87, ext. 404
For cooperation offers: grtx@grotexmed.com
Our medications: Taurine-SOLOpharm| Oxyfrin | Gylan | LinAqua | Trekrezan